Targeting APLN/APLNR improves anti-angiogenic efficiency and blunts pro-invasive side effects of VEGFA/VEGFR2-blockade in glioblastoma
Mastrella, Giorgia, Hou, Mengzhuo, Li, Min, Stoecklein, Veit M, Zdouc, Nina, Volmar, Marie N. M., Miletic, Hrvoje, Reinhard, Sören, Herold-Mende, Christel C, Kleber, Susanne, Eisenhut, Katharina, GargJournal:
Cancer Research
DOI:
10.1158/0008-5472.CAN-18-0881
Date:
February, 2019
File:
PDF, 7.32 MB
2019